Sarah is the Chief Business Officer and brings over 20 years of immunological expertise focusing on developing immuno-therapeutics across areas of Immune-Oncology, Autoimmunity, Inflammation and Infection. She has worked both as an academic and commercial immunologist recently leading UK and European teams that offer complex preclinical business development service. Sarah has a global reach and perspective across the industry; with a wealth of preclinical and clinical expertise she helps clients navigate their drug discovery programs with speed and agility. Her previous positions include Sr Client Manager at Charles River Laboratories, Business Development KWS Biotest, Research Fellowship position at the University of Bristol.
Rhiannon is the Chief Scientific officer of Nexus BioQuest and brings over 20 years’ experience working in the field of immunology across CRO and academic sectors. Her previous positions include Director of Science at Charles River Laboratories, Principal Scientist at KWS Biotest, a Wellcome Trust Career Re-entry Fellowship and a Postdoctoral fellowship at NCI, NIH. Rhiannon has a track record of strong scientific leadership; working closely with her team to identify to design custom assays, identify areas for growth and new technologies. She has a diverse background in autoimmunity, inflammation and immune-oncology and has worked with clients to design and implement research in these areas across all therapeutic modalities. She remains fascinated by the complexity of the immune system and how the latest findings and research in the field of immunology can be translated into assays to help advance clients drug discovery programs.
Peter Schmid is a founding partner of Conditor Capital. Peter has c. 30 years of experience in private equity. Most recently, he was chairman of PE investment committee of Ninety One (formerly Investec Asset Management). Previously, Peter led Private Equity business of Actis (London based PE firm with c. $15B AUM and 12 offices around the world) where he was a partner for last twelve years. He was involved in raising and deploying several private equity funds for Actis globally. Earlier, Peter was managing partner of Ethos Private Equity based in South Africa where he spent eleven years. Peter is a non-executive director of South Africa’s listed business Barloworld
Education:
- University of Witwatersrand
- Chartered Accountant
Sachin Korantak is founding partner of Conditor Capital. Sachin brings a wealth of senior level experience in private equity (PE) as an investor, operating partner, and a board member. His PE experience spans the whole investment lifecycle –from origination to value creation and board roles. His experience spans across Healthcare, Business Services, Renewable Energy, Industrials, Consumer, and Fin-Tech / SaaS sectors. Previously he has been a CEO, led performance transformations in Europe and US, and was a strategy consultant at McKinsey earlier in his career. Sachin is a true global citizen, with operating experience in Europe, USA, Asia, Africa, and Latin America. He has lived in four countries and speaks four languages.
Education:
- MBA from Ross Business School, Ann Arbor, Michigan
- Bachelor of Engineering from University of Pune
Board Member – Managing Director at Janic Capital
Adriaan is the Managing Director of Janic Capital, a permanent capital vehicle investing for the long term in high-growth private businesses across a variety of sectors and growth stages. Adriaan was previously part of Ninety One’s (formerly Investec Asset Management) private equity team where he focused on growth equity and mid-market buyout investments, and represented the Ninety One PE funds on the board of directors of several portfolio companies. Adriaan holds a MFin from the
University of Cambridge, an MSc in International Business from Edinburgh University and a BCom degree (Hons.) in Economics from Stellenbosch University.